A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response

Endocrinology

Volumn 143, Issue 3, 2002, Pages 764-774

  Weekers, Frank ^a,c   Van Herck, Erik ^a   Coopmans, Willy ^a   Michalaki, Marina ^a   Bowers, Cyril Y ^b   Veldhuis, Johannes D ^c   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCOSE; GROWTH HORMONE; INSULIN; LIOTHYRONINE; LIPID; NEUROHORMONE; PRALMORELIN; PROLACTIN; PROTIRELIN; SOMATOMEDIN C; THYROTROPIN; THYROXINE; WATER;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BURN; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE COURSE; HEMODYNAMICS; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESPONSE; HYPERCATABOLISM; IN VIVO STUDY; MALE; METABOLIC ACIDOSIS; METABOLIC DISORDER; MORTALITY; NEUROENDOCRINE SYSTEM; NONHUMAN; ORGAN WEIGHT; PARENTERAL NUTRITION; PRIORITY JOURNAL; RABBIT; STRESS; SYSTOLIC HYPERTENSION; TIME SERIES ANALYSIS; WATER CONTENT; WEIGHT REDUCTION;

EID: 0036170768     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.3.8664     Document Type: Article

References (46)

1. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients
2. Increased mortality associated with growth hormone treatment in critically ill adults
3. The somatotropic axis in critical illness: Effect of continuous growth hormone releasing hormone and GH releasing peptide-2 infusion
4. Acute and prolonged critical illness as different neuroendocrine paradigms
5. Involvement of corticotropin-releasing factor in ether stress inhibition of growth hormone secretion in the rat
6. Effects of surgical stress and corticotrophin on the peripheral metabolism of thyroid hormones in rabbits
7. Physiological control of growth hormone in the rabbit
8. A rabbit model for metabolic studies after burn injury
9. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness
10. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness
11. Early excision and grafting
12. The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats
13. The pituitary gland secretes in bursts: Appraising the nature of glandular secretary impulses by simultanuous multiple parameter deconvolution of plasma hormone concentrations
14. Approximate entropy as a measure of system complexity
15. Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strenght in humans
16. Growth hormone releasing activity of hexarelin in humans: A dose response study
17. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotropin-releasing hormone in critical illness
18. In vitro characterization of four novel classes of growth hormone-releasing peptide
19. Effects of growth hormone secretagogues on prolactin release in anesthetized dwarf (dw/dw) rats
20. Effect of an anabolic steroid on nitrogen balance and amino acid patterns after total hip replacement
21. The anemia of thermal injury: Mechanism of inhibition of erythropoiesis
22. Fluid retention and burn survival
23. Hematologic changes in massive burn injury
24. Alterations in the insulin like growth factor system in trauma patients
25. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I
26. Temporal structure of in vivo growth hormone secretory events in humans
27. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
28. Effects of a prolonged growth hormone-releasing peptide infusion on pulsatile GH secretion in normal men
29. Unnatural growth hormone-releasing peptide begets natural ghrelin
30. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation
31. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency
32. Lowering total plasma IGF-I concentrations by way of a novel, potent and selective GH-receptor antagonist, pegvisomant (B2036-PEG), augments the amplitude of GH secretory bursts and elevates basal nonpulsatile GH release in healthy women and men
33. Neuroendocrinology of prolonged critical illness: Effects of exogenous thyrotropin releasing hormone and its combination with growth hormone secretagogues
34. Metabolic acidosis inhibits growth hormone secretion in the rat. Mechanisms of growth retardation
35. Effects of acute and chronic inflammation on plasma growth hormone levels in rats
36. Decreased extrathyroidal triiodothyronine production in non thyroidal illness: Benefit or harm?
37. Dangerous dogmas in medicine: The nonthyroidal illness syndrome
38. Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis
39. Suppression of thyrotropin releasing hormone gene expression by interleukin-1-β in the rat: Implications for non-thyroid illness
40. Circulating thyroid hormone changes in acute trauma: Prognostic implications for clinical outcome
41. Pituitary-thyroid function in patients with septic shock and its relation with outcome
42. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness
43. Shift in adenohypophyseal activity during chronic intermittent immobilization of rats
44. Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities
45. Growth hormone releasing peptide-2 infusion synchronizes growth hormone, thyrotropin and prolactin release in prolonged critical illness